• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小病变肾病复发患者的血清增加了培养的足细胞中 CD80 的表达。

Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes.

机构信息

Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, CO, USA.

出版信息

Pediatr Nephrol. 2013 Sep;28(9):1803-12. doi: 10.1007/s00467-013-2498-4. Epub 2013 May 21.

DOI:10.1007/s00467-013-2498-4
PMID:23689904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3723775/
Abstract

BACKGROUND

Minimal change disease (MCD) is the most common cause of nephrotic syndrome in children and is associated with the expression of CD80 in podocytes and the increased excretion of CD80 in urine. We hypothesized that serum from patients with MCD might stimulate CD80 expression in cultured podocytes.

METHODS

Sera and peripheral blood mononuclear cells (PBMCs) were collected from subjects with MCD in relapse and remission and from normal controls. Immortalized human podocytes were incubated with culture media containing patient sera or supernatants from patient and control PBMC cultures. CD80 expression was measured by quantitative PCR and western blot analysis.

RESULTS

Sera collected from patients with MCD in relapse, but not in remission, significantly increased CD80 expression (mean ± standard deviation: 1.8 ± 0.7 vs. 0.8 ± 0.2; p < 0.004) and CD80 protein secretion by podocytes (p < 0.05 between relapse and normal controls). No such CD80 increase was observed when podocytes were incubated with supernatants of PBMC cultures from patients in relapse.

CONCLUSIONS

Sera from MCD patients in relapse, but not in remission, stimulated CD80 expression in cultured podocytes. Identifying this factor in sera could provide insights into the pathogenesis of this disorder. No role in CD80 expression by podocytes was found for cytokines released by PBMCs.

摘要

背景

微小病变性肾病(MCD)是儿童肾病综合征最常见的病因,与足细胞中 CD80 的表达和 CD80 在尿液中的排泄增加有关。我们假设 MCD 患者的血清可能会刺激培养的足细胞中 CD80 的表达。

方法

从 MCD 复发和缓解期的患者和正常对照中收集血清和外周血单核细胞(PBMC)。将永生化的人足细胞与含有患者血清或患者和对照 PBMC 培养物上清液的培养基一起孵育。通过定量 PCR 和 Western blot 分析来测量 CD80 的表达。

结果

来自 MCD 复发患者的血清,但不是缓解期患者的血清,显著增加了足细胞的 CD80 表达(平均值 ± 标准差:1.8 ± 0.7 与 0.8 ± 0.2;p < 0.004)和 CD80 蛋白分泌(复发与正常对照组之间 p < 0.05)。当将足细胞与来自复发患者的 PBMC 培养物上清液孵育时,未观察到这种 CD80 增加。

结论

来自 MCD 复发患者的血清,但不是缓解期患者的血清,刺激了培养的足细胞中 CD80 的表达。在血清中鉴定出这种因子可以深入了解该疾病的发病机制。在 PBMC 释放的细胞因子对足细胞 CD80 表达中未发现作用。

相似文献

1
Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes.微小病变肾病复发患者的血清增加了培养的足细胞中 CD80 的表达。
Pediatr Nephrol. 2013 Sep;28(9):1803-12. doi: 10.1007/s00467-013-2498-4. Epub 2013 May 21.
2
Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?微小病变病:足细胞CD80 - CTLA - 4轴的失调?
Pediatr Nephrol. 2014 Dec;29(12):2333-40. doi: 10.1007/s00467-014-2874-8. Epub 2014 Jul 14.
3
Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice.Toll 样受体 3 配体聚肌苷酸诱导蛋白尿和肾小球 CD80,并增加小鼠尿液中 CD80 的含量。
Nephrol Dial Transplant. 2013 Jun;28(6):1439-46. doi: 10.1093/ndt/gfs543. Epub 2012 Dec 21.
4
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.微小病变病和局灶节段性肾小球硬化症患者的CD80和可溶性尿激酶型纤溶酶原激活物受体:诊断及致病意义
Pediatr Nephrol. 2014 Aug;29(8):1363-71. doi: 10.1007/s00467-013-2679-1. Epub 2013 Nov 22.
5
Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.微小病变病复发患者的肾小球内皮细胞和足细胞可表达CD80。
Pediatr Nephrol. 2020 Oct;35(10):1887-1896. doi: 10.1007/s00467-020-04541-3. Epub 2020 May 12.
6
Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.特发性肾病综合征患儿外周血单个核细胞中Toll样受体3(TLR-3)、TLR-4及CD80的表达以及尿CD80水平
Pediatr Nephrol. 2017 Aug;32(8):1355-1361. doi: 10.1007/s00467-017-3613-8. Epub 2017 Feb 16.
7
Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.尿CD80作为小儿微小病变病诊断中肾活检的替代指标
Iran J Kidney Dis. 2018 Mar;12(2):107-111.
8
Urinary CD80 excretion increases in idiopathic minimal-change disease.特发性微小病变病患者尿中CD80排泄增加。
J Am Soc Nephrol. 2009 Feb;20(2):260-6. doi: 10.1681/ASN.2007080836. Epub 2008 Dec 3.
9
Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.尿 CD80 在微小病变性肾病中升高,但在局灶节段性肾小球硬化症中不升高。
Kidney Int. 2010 Aug;78(3):296-302. doi: 10.1038/ki.2010.143. Epub 2010 May 19.
10
Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway.Toll 样受体 3 配体通过 NF-κB 依赖途径诱导人足细胞 CD80 的表达。
Nephrol Dial Transplant. 2012 Jan;27(1):81-9. doi: 10.1093/ndt/gfr271. Epub 2011 May 26.

引用本文的文献

1
Exploring the significance of interleukin-33/ST2 axis in minimal change disease.探讨白细胞介素-33/ST2 轴在微小病变病中的意义。
Sci Rep. 2023 Oct 31;13(1):18776. doi: 10.1038/s41598-023-45678-z.
2
The fructose survival hypothesis for obesity.肥胖的果糖生存假说。
Philos Trans R Soc Lond B Biol Sci. 2023 Sep 11;378(1885):20220230. doi: 10.1098/rstb.2022.0230. Epub 2023 Jul 24.
3
The immunopathogenesis of idiopathic nephrotic syndrome: a narrative review of the literature.特发性肾病综合征的免疫发病机制:文献综述

本文引用的文献

1
Scavenger receptor A (SR-A) is required for LPS-induced TLR4 mediated NF-κB activation in macrophages.清道夫受体A(SR-A)是巨噬细胞中脂多糖(LPS)诱导的Toll样受体4(TLR4)介导的核因子κB(NF-κB)激活所必需的。
Biochim Biophys Acta. 2012 Jul;1823(7):1192-8. doi: 10.1016/j.bbamcr.2012.05.004. Epub 2012 May 14.
2
Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway.Toll 样受体 3 配体通过 NF-κB 依赖途径诱导人足细胞 CD80 的表达。
Nephrol Dial Transplant. 2012 Jan;27(1):81-9. doi: 10.1093/ndt/gfr271. Epub 2011 May 26.
3
Minimal change disease: a "two-hit" podocyte immune disorder?
Eur J Pediatr. 2022 Apr;181(4):1395-1404. doi: 10.1007/s00431-021-04357-9. Epub 2022 Jan 31.
4
Molecular Mechanisms of Proteinuria in Minimal Change Disease.微小病变性肾病蛋白尿的分子机制
Front Med (Lausanne). 2021 Dec 23;8:761600. doi: 10.3389/fmed.2021.761600. eCollection 2021.
5
Trends in pediatric nephrotic syndrome.小儿肾病综合征的趋势
World J Nephrol. 2021 Sep 25;10(5):88-100. doi: 10.5527/wjn.v10.i5.88.
6
Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig-to-baboon xenotransplantation.人CD47在猪肾小球中的表达可预防蛋白尿,并延长猪到狒狒异种移植后的移植物存活时间。
Xenotransplantation. 2021 Nov;28(6):e12708. doi: 10.1111/xen.12708. Epub 2021 Aug 21.
7
How immunosuppressive drugs may directly target podocytes in glomerular diseases.免疫抑制药物如何在肾小球疾病中直接靶向足细胞。
Pediatr Nephrol. 2022 Jul;37(7):1431-1441. doi: 10.1007/s00467-021-05196-4. Epub 2021 Jul 9.
8
CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.CD80 靶点的研究进展及其在频繁复发型微小病变肾病治疗中的应用
Biomed Res Int. 2021 Jan 6;2021:6671552. doi: 10.1155/2021/6671552. eCollection 2021.
9
MicroRNAs as Biomarkers for Nephrotic Syndrome.微小 RNA 作为肾病综合征的生物标志物。
Int J Mol Sci. 2020 Dec 23;22(1):88. doi: 10.3390/ijms22010088.
10
Urinary CD 80 in Nephrotic Syndrome: A Biomarker to Distinguish Minimal Change Disease From Other Glomerular Diseases.肾病综合征中的尿CD80:一种区分微小病变病与其他肾小球疾病的生物标志物。
Kidney Int Rep. 2020 Sep 28;5(11):1851-1852. doi: 10.1016/j.ekir.2020.09.027. eCollection 2020 Nov.
微小病变性肾病:一种“双打击”的足细胞免疫性疾病?
Pediatr Nephrol. 2011 Apr;26(4):645-9. doi: 10.1007/s00467-010-1676-x. Epub 2010 Oct 30.
4
Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.尿 CD80 在微小病变性肾病中升高,但在局灶节段性肾小球硬化症中不升高。
Kidney Int. 2010 Aug;78(3):296-302. doi: 10.1038/ki.2010.143. Epub 2010 May 19.
5
TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.Toll样受体3配体诱导核因子-κB活化以及多发性骨髓瘤细胞的多种命运,这取决于α干扰素的产生。
J Immunol. 2009 Apr 1;182(7):4471-8. doi: 10.4049/jimmunol.0803113.
6
Urinary CD80 excretion increases in idiopathic minimal-change disease.特发性微小病变病患者尿中CD80排泄增加。
J Am Soc Nephrol. 2009 Feb;20(2):260-6. doi: 10.1681/ASN.2007080836. Epub 2008 Dec 3.
7
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats.白细胞介素-13的过表达可诱导大鼠发生微小病变样肾病。
J Am Soc Nephrol. 2007 May;18(5):1476-85. doi: 10.1681/ASN.2006070710. Epub 2007 Apr 11.
8
Proteinuria and fusion of podocyte foot processes in rats after infusion of cytokine from patients with idiopathic minimal lesion nephrotic syndrome.特发性微小病变肾病综合征患者细胞因子输注后大鼠的蛋白尿和足细胞足突融合
Nephron Exp Nephrol. 2006;102(3-4):e105-12. doi: 10.1159/000089689. Epub 2005 Dec 5.
9
Rhinovirus viremia in children with respiratory infections.呼吸道感染儿童的鼻病毒血症
Am J Respir Crit Care Med. 2005 Oct 15;172(8):1037-40. doi: 10.1164/rccm.200502-315OC. Epub 2005 Jun 30.
10
The B7 family revisited.重新审视B7家族。
Annu Rev Immunol. 2005;23:515-48. doi: 10.1146/annurev.immunol.23.021704.115611.